Oxford has been approved for use in the United Kingdom, the government announced on Wednesday, adding the mass rollout will begin on 4 January.Britain health regulators recommended two doses in an interval of four and 12 weeks.
The administration, shown in clinical trials, has been found to be safe and effective in the battle against the pandemic and will lead to a massive expansion in Britain's immunisation programme.Also Read | Ten books from 2020 you must not miss"This regimen was shown in clinical trials to be safe and effective at preventing symptomatic Covid-19, with no severe cases and no hospitalisations more than 14 days after the second dose," an official release by AstraZeneca read."The government has today accepted the.